![](/img/cover-not-exists.png)
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
Baselga, J., Manikhas, A., Cortes, J., Llombart, A., Roman, L., Semiglazov, V. F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R. H., Matera, J., Azarnia, N., Hudis, C. A., Rozencweig, M.Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt543
Date:
March, 2014
File:
PDF, 273 KB
english, 2014